Seth Loring Harrison, Director, 10% Owner at Akero Therapeutics, Inc. (AKRO), bought 5,128,764 shares at $16.00 ($14.4M) on 2019-06-24, disclosed to the SEC on 2019-06-25.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 4,228,764 | $0 | 0.0% |
| 2 | $16.00 | 900,000 | $14.4M | 100.0% |
| Total | $2.81 avg | 5,128,764 | $14.4M | 100% |
| Filing → |
| AKRO | SELL | 2022-10-27 | $24.4M | — | Filing → |
| STOK | BUY | 2020-11-25 | $14.6M | — | Filing → |
| AKRO | BUY | 2020-07-14 | $14.9M | — | Filing → |